IBDEI0ZV ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17727,1,5,0)
 ;;=5^Wandering-Dis Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,17727,2)
 ;;=^340621
 ;;^UTILITY(U,$J,358.3,17728,0)
 ;;=V40.39^^95^997^37
 ;;^UTILITY(U,$J,358.3,17728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17728,1,2,0)
 ;;=2^V40.39
 ;;^UTILITY(U,$J,358.3,17728,1,5,0)
 ;;=5^Oth Specified Behavioral Problem
 ;;^UTILITY(U,$J,358.3,17728,2)
 ;;=^340622
 ;;^UTILITY(U,$J,358.3,17729,0)
 ;;=V65.19^^95^997^45
 ;;^UTILITY(U,$J,358.3,17729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17729,1,2,0)
 ;;=2^V65.19
 ;;^UTILITY(U,$J,358.3,17729,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,17729,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,17730,0)
 ;;=V66.7^^95^997^5
 ;;^UTILITY(U,$J,358.3,17730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17730,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,17730,1,5,0)
 ;;=5^Encounter for Palliative Care
 ;;^UTILITY(U,$J,358.3,17730,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,17731,0)
 ;;=V11.4^^95^997^18
 ;;^UTILITY(U,$J,358.3,17731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17731,1,2,0)
 ;;=2^V11.4
 ;;^UTILITY(U,$J,358.3,17731,1,5,0)
 ;;=5^Hx Combat/Operational Stress
 ;;^UTILITY(U,$J,358.3,17731,2)
 ;;=^339674
 ;;^UTILITY(U,$J,358.3,17732,0)
 ;;=V60.1^^95^997^20
 ;;^UTILITY(U,$J,358.3,17732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17732,1,2,0)
 ;;=2^V60.1
 ;;^UTILITY(U,$J,358.3,17732,1,5,0)
 ;;=5^Inadequate Housing
 ;;^UTILITY(U,$J,358.3,17732,2)
 ;;=^295540
 ;;^UTILITY(U,$J,358.3,17733,0)
 ;;=V62.84^^95^997^49
 ;;^UTILITY(U,$J,358.3,17733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17733,1,2,0)
 ;;=2^V62.84
 ;;^UTILITY(U,$J,358.3,17733,1,5,0)
 ;;=5^Suicidal Ideation
 ;;^UTILITY(U,$J,358.3,17733,2)
 ;;=^332876
 ;;^UTILITY(U,$J,358.3,17734,0)
 ;;=V62.85^^95^997^16
 ;;^UTILITY(U,$J,358.3,17734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17734,1,2,0)
 ;;=2^V62.85
 ;;^UTILITY(U,$J,358.3,17734,1,5,0)
 ;;=5^Homicidal Ideation
 ;;^UTILITY(U,$J,358.3,17734,2)
 ;;=^339690
 ;;^UTILITY(U,$J,358.3,17735,0)
 ;;=V58.61^^95^997^23
 ;;^UTILITY(U,$J,358.3,17735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17735,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,17735,1,5,0)
 ;;=5^L/T (Current) Anticoagulant Use
 ;;^UTILITY(U,$J,358.3,17735,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,17736,0)
 ;;=V58.62^^95^997^22
 ;;^UTILITY(U,$J,358.3,17736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17736,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,17736,1,5,0)
 ;;=5^L/T (Current) Antibiotics Use
 ;;^UTILITY(U,$J,358.3,17736,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,17737,0)
 ;;=V58.63^^95^997^24
 ;;^UTILITY(U,$J,358.3,17737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17737,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,17737,1,5,0)
 ;;=5^L/T (Current) Antiplts/Antithrmbtcs
 ;;^UTILITY(U,$J,358.3,17737,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,17738,0)
 ;;=V58.64^^95^997^28
 ;;^UTILITY(U,$J,358.3,17738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17738,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,17738,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,17738,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,17739,0)
 ;;=V58.65^^95^997^30
 ;;^UTILITY(U,$J,358.3,17739,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17739,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,17739,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,17739,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,17740,0)
 ;;=V58.66^^95^997^25
 ;;^UTILITY(U,$J,358.3,17740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17740,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,17740,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,17740,2)
 ;;=^331584
